EUTECNIQ Sciences

See every page on one mapArrow keys move through results · Enter opens · Esc closes

Company · business model

Three businesses, one scientific engine.

The Large Botanical Model is the core technology. Regulatory and development solutions are its first commercial use and the place its models are validated. Owned ingredients and intellectual property are a longer-term way to create value from the same capabilities.

ProposedNo product, customer, license or revenue exists yet. This page describes the intended model; prices and terms are not published.

01 · The model

Projects pay first; validated capabilities become products.

Business 1 · later

Enterprise scientific AI platform

Software licenses, subscriptions, specialized research modules, API access and data-supported development workflows.

Future product

Business 2 · first

Regulatory and development solutions

Model-assisted NDI assessment, NDIN dossier support, ingredient qualification, safety-gap analysis, extraction and formulation development, targeted experimental programs with partners.

Workflow demonstrated

Business 3 · after validation

Proprietary ingredients and IP

Promising botanical ingredients, optimized processes, delivery technologies and standardized formulations, protected where possible and commercialized by license, partners or supply.

Future objective

Every project is designed to leave a validated method, a benchmark or, with permission, data that improve the platform.

  1. Fixed-scope projectsFeasibility, dossier support and development programs, priced per decision.
  2. Validated modulesWorkflows that pass their benchmarks become reusable platform modules.
  3. Recurring accessClients with repeat needs move to subscriptions and API access.
  4. Owned programsValidated capabilities applied to EUTECNIQ-funded ingredients and licensed.

02 · Customers

Who would pay, for what, and when.

Customer segments
SegmentTheir problemWhat they would buyBusinessWhen
International botanical suppliersAn ingredient used abroad needs a U.S. pathway and evidenceNDI feasibility; identity and contaminant packages; dossier supportBusiness 2First
U.S. supplement brands and distributorsA new botanical must be qualified before launchSupplier qualification; specification; safety-gap analysisBusiness 2, then 1First
Ingredient manufacturersStandardization, process and formulation for a defined ingredientModel-guided extraction and formulation programsBusiness 2, then 1First
CROs and CDMOsBetter-chosen studies and processes for their own clientsPlatform modules and API accessBusiness 1Later
Pharmaceutical, cosmetic and personal-care developersIngredient intelligence under their own pathwaysPlatform access; partnered programsBusiness 1Later
Licensees and partnersAn owned, documented ingredient or processLicenses, partner manufacturing, supplyBusiness 3After validation

Segments are the intended order of entry, not existing customers. The first market test is whether clients pay for a better-founded decision on a botanical candidate.

03 · Data rights

Customer data stay the customer’s.

Default

Not training data

Customer proprietary data are used only for that customer’s work and do not become EUTECNIQ training data unless the customer agrees in writing.

Ownership

Clear in every contract

Clients own their deliverables; EUTECNIQ keeps its pre-existing and general methods. EUTECNIQ owns everything from its own programs.

Provenance

Only data with rights

Shared models are trained only on public, licensed or EUTECNIQ-generated data for which EUTECNIQ holds explicit rights, with the source recorded.

Audit

Traceable outputs

Every prediction and dossier statement can be traced to its inputs, model version and sources.

04 · Defensibility

What would be hard to copy, and what would not.

Many companies use AI and molecular modeling; EUTECNIQ does not claim otherwise. Defensibility would come from what accumulates: lawfully generated and licensed datasets, validated algorithms, experimental relationships that are hard to reproduce, specialized workflows, process know-how, technical partnerships and inventions protected where they are new and non-obvious. None of these exists at scale yet; building them is the plan.

Information only; not an offer of securities.

Health information notice. These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease, and nothing here is medical advice.

Read the full notice

The information is for general education only. It does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed. Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to start a development project?

Tell us about an ingredient you want to specify, verify or license. Questions? Email [email protected]